City Therapeutics logo

City Therapeutics

Cambridge, MA

City Therapeutics is a biopharmaceutical company focusing on engineering next-generation small-interfering RNAs (siRNAs) to enhance RNAi-based therapies. The company develops a pipeline of innovative RNAi therapeutics aimed at addressing various disease indications. City Therapeutics prioritizes improving and expanding RNAi technology to achieve better patient outcomes. The leadership team includes experienced scientists and industry professionals dedicated to advancing the field of RNA interference.

citytx.com

Company Details

Founded

Employees

Between 10 - 50 employees

Raised

$135,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

Andy OrthAndy Orth

Founders

John Maraganore
John Maraganore
Sebastian Trousil
Sebastian Trousil
Robert Nelsen
Robert Nelsen
Ari Nowacek
Ari Nowacek

Company Collections

These are collections City Therapeutics is a part of. Click on the collection name to view similar companies.

City Therapeutics' Industries

Current Job Listings

Listing 0 of 4 job openings

    City Therapeutics Headquarters Location

    399 Binney Street, Cambridge, MA 02142

    Total Amount Raised: $135,000,000

    City Therapeutics Funding Rounds

    • Series A

      $135,000,000

      Series A Investors

      Arch Venture Partners
      Rock Springs Capital
      Slate Path Capital
      Fidelity Investments
      Invus Group
      AN Ventures
      Regeneron Ventures
    Funding info provided by Diffbot.

    City Therapeutics Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on City Therapeutics.

    Recent reviews